Hotel Palace Berlin Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

21st-Century Drug Discovery and Development for Global Health (S3)

Scientific Organizers: Ken Duncan, Elizabeth Winzeler and Lluís Ballell


October 17—20, 2018

Hotel Palace Berlin, Berlin, Germany


Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation


Abstract submission is now closed. Registered attendees may bring a poster onsite. Please contact our office at +1 800-253-0685; +1 970-262-1230 or email info@keystonesymposia.org if you are interested.
BEWARE of booking lodging through companies unaffiliated with Keystone Symposia. Click here for more details.

Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.

DEADLINES:
*All deadlines end at 11:59 PM US Mountain Standard Time
Global Health Travel Award Deadline: May 15, 2018 [details]
Scholarship Deadline: Jun 19, 2018 [details]
Discounted Abstract Deadline: Jun 19, 2018 [details]
Abstract Deadline: Jul 17, 2018 [details]
Discounted Registration Deadline: Aug 16, 2018 [details]

Click here to view Cancellation Policy

Register Yourself Deadlines and Fees

Rates and Deadlines listed below are for the 2019-S3 "21st-Century Drug Discovery and Development for Global Health" conference only.

*All deadlines end at 11:59 PM US Mountain Standard Time

Deadline Date Cost
Discounted Abstract Deadline
More details
Before and On June 19, 2018 100.00 USD*
- 50.00 USD discount
Abstract Deadline
More details
After June 19, 2018 until September 5, 2018 100.00 USD*
* 50.00 USD of Abstract fee deducted from your registration fee when you register for this meeting
Scholarship
More details
June 19, 2018 n/a
Discounted NON-STUDENT Registration
More details
Before and On August 16, 2018 895.00 USD
(includes 200.00 discount)
Regular NON-STUDENT Registration
More details
After August 16, 2018 1095.00 USD
Discounted STUDENT Registration
More details
Before and On August 16, 2018 670.00 USD
(includes 200.00 discount)
Regular STUDENT Registration
More details
After August 16, 2018 870.00 USD

* Changes in payment type that result in a refund are subject to a processing fee.
* Currency exchange gains/losses are the responsibility of the registrant and the Keystone Symposia will accept no liability for money loss through bank charges, transfers or currency fluctuations.




Discounted Abstract Deadline: June 19, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time

Abstract Submission Fee: 100.00 USD*
Submission by this date receives 50.00 USD discount.
*50.00 USD will be applied to Registration Fee when you register

Abstract Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadlines. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract early allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • accept your abstract online
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
(The Abstract Deadline: is July 17, 2018)

Global Health Travel Award Deadline: May 15, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time


Global Health Travel Award Details: You MUST complete your Global Health Travel Award appplication by the Global Health Travel Award Deadline and complete the other required steps (verify your contact information and submit a recommendation letter) to be considered for a travel award.


Click here to learn more about Global Health Travel Awards.

Scholarship Deadline: June 19, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time


Scholarship Details: You MUST submit your abstract by the Scholarship Deadline and complete the other required steps (submit a scholarship application and submit a mentor letter) to be considered for a scholarship.

Click here to learn more about Scholarships.

Abstract Deadline: July 17, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time


Abstract Submission Fee: 100.00 USD*
*50.00 USD will be applied to Registration Fee when you register

Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadline. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract by the Abstract Deadline allows us to:

  • submit your abstract to organizers to be considered for a short talk
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
Abstracts submitted after the Abstract Deadline will NOT be considered for a short talk.

(Discounted Abstract Deadline: is June 19, 2018)

Discounted Registration Deadline: August 16, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time


Registration Fee: 895.00 USD* (includes 200.00 USD discount)
Student Registration Fee: 670.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

After the Discounted Registration Deadline:


Registration Fee: 1095.00 USD*
Student Registration Fee: 870.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

Registration spaces are limited and may fill prior to discounted registration deadline.

Please be advised that some meeting participants have received calls and emails from a number of different housing services, including "Exhibitors Housing Services," “Expo Housing Services,” "Global Housing," etc. THESE COMPANIES ARE NOT AFFILIATED WITH KEYSTONE SYMPOSIA and are not authorized by Keystone Symposia to contact you. These companies may tell you that the meeting is filling, without any actual knowledge to that effect, and pressure you into giving them your credit card number to make a lodging reservation with them.

We highly recommend that you not make a reservation with these companies or any other housing service! These companies' representations to participants have been misleading. Please report any calls or correspondence you might have received to Keystone Symposia and book only through lodging links in your Keystone Symposia account, an established travel agency or directly with the hotel(s) listed on our website.
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


The meeting will begin on Wednesday, October 17 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Saturday, October 20 with a closing plenary session from 17:00 to 19:00, followed by a social hour and entertainment. We recommend return travel on Sunday, October 21 in order to fully experience the meeting.

WEDNESDAY, OCTOBER 17

16:00—20:00
Arrival and Registration

Foyer 2nd Floor
18:00—20:00
Welcome Mixer
No registration fees are used to fund alcohol served at this function.

Foyer 2nd Floor

THURSDAY, OCTOBER 18

08:00—09:50
New Therapeutics for Global Health
Registered attendees can view abstracts starting on 09/17/2018

Bordeaux I-II
* Ken Duncan, Bill & Melinda Gates Foundation, USA

Nathalie Strub Wourgaft, Drugs for Neglected Diseases Initiative, DNDi, Switzerland
Transformative New Therapies for Human African trypanosomiasis

Thierry T. Diagana, Novartis Institute for Tropical Diseases, USA
Progress with the Clinical Development of Cipargamin (KAE609) and Ganaplacide (KAF156) for the Treatment of Malaria

Lluís Ballell, GlaxoSmithKline, Spain
Global Health GSK R&D in Tres Cantos – Introducing GSK701 and GSK286 as Novel Preclinical Candidates against Malaria and TB

Joseph D. Turner, Liverpool School of Tropical Medicine, UK
Short Talk: Novel Anti-Wolbachia Drugs as Short-Course Macrofilaricides for Onchocerciasis

10:10—12:00
Robust Target Validation – What Does it Mean?
Registered attendees can view abstracts starting on 09/17/2018

Bordeaux I-II
* Tanya Parish, Infectious Disease Research Institute, USA

Elizabeth A. Winzeler, University of California, San Diego, USA
Multidisciplinary Approaches to the Discovery of Chemoprotective Drugs and Targets for Malaria

Dirk Schnappinger, Weill Cornell Medical College, USA
Combining Chemical Probes and Genetic Knockdowns to Validate Drug Targets in Mycobacterium tuberculosis

Boris Striepen, University of Pennsylvania, USA
Using Molecular Genetics to Understand and Combat Cryptosporidium

Andrew Fraser, University of Toronto, Canada
Short Talk: Dissecting the Pathway for Rhodoquinone Biosynthesis in C. elegans: It all Starts at the Beginning

12:00—13:00
Transfer to Grand Challenges Event at Estrel Congress Center

12:30—13:30
Lunch with Grand Challenges

Estrel Congress Ctr, Convention Hall I-A/B
13:30—16:00
Joint Keynote Session and Panel Discussion with Grand Challenges: Innovation in Drug Discovery
Keynote
Ken Duncan, The Bill & Melinda Gates Foundation, USA

Spotlight Talk
Kelly Chibale, University of Cape Town, South Africa

Panel Discussion: Combatting Antimicrobial Resistance through Drug Discovery and Innovation
*Sally Davies, UK Department of Health, UK
Stephen Baker, University of Oxford, UK
Renu Swarup, Department of Biotechnology, India

Closing Keynote
Lynda Stuart, The Bill & Melinda Gates Foundation, USA

Estrel Convention Hall II
16:00—17:00
Networking and Welcome Mixer with Grand Challenges and Keystone Symposia

Estrel Congress Ctr, Convention Hall I-A/B
17:00—18:00
Return Transfer to Hotel

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Burgund I-III

FRIDAY, OCTOBER 19

08:00—11:00
Importance of Chemical Diversity in Seeking New Leads
Registered attendees can view abstracts starting on 09/17/2018

Bordeaux I-II
* Courtney Cortez Aldrich, University of Minnesota, USA

Xiaopeng Bai, GlaxoSmithKline, USA
Experience with DNA-Encoded Libraries in Search for New Leads against TB

E. Paige Stout, Sirenas, USA
Sirenas Biochemometrics Platform: Transforming the Search for New Medicines

Coffee Break

Judy A. Sakanari, University of California, San Francisco, USA
Identifying Anti-Filarial Candidates using a Multifaceted Screening Funnel

Charles E. Mowbray, Drugs for Neglected Diseases Initiative, Switzerland
A New Era of Orally Active Treatments for Leishmaniasis Patients

Jennifer Elizabeth Collins, University of Central Florida, USA
Short Talk: Novel Antiplasmodial Compounds from Fungi

11:00—17:00
On Own for Lunch

11:00—13:00
Poster Setup

Burgund I-III
13:00—22:00
Poster Viewing

Burgund I-III
16:30—17:00
Coffee Available

Burgund I-III
17:00—19:00
Alternative Approaches to Drug Delivery – Opportunities and Challenges
Registered attendees can view abstracts starting on 09/17/2018

Bordeaux I-II
* Anna Upton, TB Alliance, USA

Paul L. Feldman, Intarcia Therapeutics, USA
Application of the Intarcia Medici Drug Delivery SystemTM for Long-Acting HIV Prevention for Global Health

Andrew Martin Bellinger, Lyndra, USA
Development of Oral, Ultra Long-Lasting, Sustained Release Therapies in the Fight against Malaria and HIV

Arnab Chatterjee, Calibr, USA
Chemoprophylaxis for Prevention of Malaria Infection

Daniel Greenwood, Francis Crick Institute, UK
Short Talk: Subcellular Antibiotic Visualisation Reveals a Dynamic Drug Reservoir in Mycobacterium tuberculosis-Infected Macrophages

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Burgund I-III
19:30—22:00
Poster Session 1

Burgund I-III

SATURDAY, OCTOBER 20

07:00—08:00
Poster Setup

Burgund I-III
08:00—17:00
Poster Viewing

Burgund I-III
08:00—11:15
Improving Target and Phenotypic-Based Approaches
Registered attendees can view abstracts starting on 09/17/2018

Bordeaux I-II
* Anil Koul, Institute of Microbial Technology, India

Leann M. Tilley, University of Melbourne, Australia
The Proteasome as a Target for New Antimalarial Drugs

Kirsten Hanson, University of Texas at San Antonio, USA
Profiling Compounds against Liver Stage Malaria

Beatriz Baragana, University of Dundee, UK
Short Talk: Lysyl tRNA Synthetase as a Drug Target in Apicomplexan Parasites

Nyssa Drinkwater, Monash University, Australia
Short Talk: Rational Design of a Multi-Target Antimalarial Compound with in vivo Activity

Coffee Break

Deborah T. Hung, Broad Institute of MIT & Harvard, USA
Multiplex Screening of an M. tuberculosis Hypomorph Library Simultaneously Identifies Lead and Target

Marc Gitzinger, BioVersys AG, Switzerland
A SMARt Approach to Reversing Drug Resistance in TB and Deploying the Hidden Potential of Current TB Drugs

Bryan J. Berube, Infectious Disease Research Institute, USA
Short Talk: MenA Inhibitors Are Bactericidal against Mycobacterium tuberculosis Alone and in Combination with Electron-Transport Chain Inhibitors

11:15—12:30
Lunch

Burgund I-III
12:00—14:30
Poster Session 2

Burgund I-III
14:30—16:30
Workshop: Opportunities for Repurposing to Discover New Candidates or Mature Starting Points

Bordeaux I-II
* Elnaz Menhaji-Klotz, Bill & Melinda Gates Medical Research Institute, USA

* Khisimuzi E. Mdluli, Bill & Melinda Gates Medical Research Institute, USA

Oluyomi S. Adeyemi, Landmark University, Nigeria
Drug Repurposing and Screening of Libraries of Chemical Compounds to Identify New Anti-Parasitic Agents

Samuel Arnold, University of Washington, USA
A Second Chance for Your Favorite Protozoan Target: Repositioning Opportunities for Treatment of Cryptosporidosis

Giancarlo Biagini, Liverpool School of Tropical Medicine, UK
Antimalarial Pharmacology of Primaquine: Attempting to Solve a 70-Year-Old Puzzle

Elena Fernandez Alvaro, GlaxoSmithKline, Spain
Repurposing Opportunities for the Treatment of MDR Bacterial Enteric Infections

Malkeet Kumar, University of Cape Town, South Africa
Repositioning the Antihistamine Drug Astemizole as an Anti-Plasmodial Agent

Rob Leurs, Vrije Universiteit Amsterdam, Netherlands
Parasite-Specific Cyclic Nucleotide Phosphodiesterase Inhibitors to Target Neglected Parasitic Diseases (PDE4NPD)

Rose C. Lopeman, Aston University, UK
Faropenem and Clavulanate Exhibit Additive Effect against Mycobacterium abscessus in vitro

16:30—17:00
Coffee Available

Burgund I-III
17:00—18:45
Translational Tools for Predicting Efficacy and Resistance
Registered attendees can view abstracts starting on 09/17/2018

Bordeaux I-II
* Robert S. Wallis, Aurum Institute, South Africa

Wesley C. Van Voorhis, University of Washington, USA
Pharmacodynamic Modeling of Anti-Cryptosporidium Drug Efficacy

Yingda L. Xie, NIAID, National Institutes of Health, USA
Improving Phase 2a TB Drug Development Models through PET/CT Imaging (NexGen EBA)

Cristina Donini, Medicines for Malaria Venture, Switzerland
Role of Volunteer Infection Studies in Prioritizing the Next Generation of Clinical Candidates in Malaria

Thomas Spangenberg, Merck, Switzerland
Short Talk: Evaluation of the Pharmacokinetic-Pharmacodynamic Relationship of Praziquantel in the Schistosoma mansoni Mouse Model

18:45—19:00
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 09/17/2018

Bordeaux I-II
19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Burgund I-III
20:00—23:00
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Burgund I-III

SUNDAY, OCTOBER 21

 
Departure


*Session Chair †Invited, not yet responded.



Keystone Symposia thanks our Sponsor for generously supporting this meeting:

Bill & Melinda Gates Foundation

We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:



BioVersys AG


Intarcia Therapeutics, Inc.


Sirenas


We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Director of Development, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676